ResearcherFudan UniversityActive in the last 2 years
Bo Yu
Matched on ORCID iD 0000-0002-5090-7706; OpenAlex author ID A5101556289. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 2
- [Retracted] Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluoroura… Last author DOI 10.3892/etm.2026.13235↗
- Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases chemosensitivity to 5-fluorouracil and gemc… Last author DOI 10.3892/etm.2018.7112↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qi Zou · 2 shared papers, 2019–2026 · strength 0.47
- Paper [Retracted] Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and i… DOI 10.3892/etm.2026.13235↗
- Paper Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases che… DOI 10.3892/etm.2018.7112↗
- Xiaoping Yang · 2 shared papers, 2019–2026 · strength 0.47
- Paper [Retracted] Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and i… DOI 10.3892/etm.2026.13235↗
- Paper Downregulation of miR-183 inhibits the growth of PANC-1 pancreatic cancer cells in vitro and in vivo, and increases che… DOI 10.3892/etm.2018.7112↗
- Wei Wang · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.